p27: A potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior
Authors:
- 1 October 2001
- journal article
- Published by Elsevier in Human Pathology
- Vol. 32 (10) , 1094-1101
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human CancersThe American Journal of Pathology, 1999
- The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human CancerAnnual Review of Medicine, 1999
- Prognostic criteria in nonfunctioning pancreatic endocrine tumoursVirchows Archiv, 1996
- Role of the cyclin-dependent kinase inhibitors in the development of cancerBlood, 1995
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Principles of CDK regulationNature, 1995
- p53-Independent Expression of p21 Cip1 in Muscle and Other Terminally Differentiating CellsScience, 1995
- pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrestNature, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- Immunodetection of Proliferating Cell Nuclear Antigen Assesses the Growth Fraction and Predicts Malignancy in Endocrine Tumors of the PancreasAmerican Journal of Surgical Pathology, 1992